Truist Financial Forecasts Strong Price Appreciation for Amrize (NYSE:AMRZ) Stock

Amrize (NYSE:AMRZ) had its price objective raised by equities researchers at Truist Financial from $60.00 to $75.00 in a research report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price would suggest a potential upside of 15.77% from the stock’s previous close.

A number of other brokerages have also weighed in on AMRZ. Stephens initiated coverage on shares of Amrize in a research note on Friday, November 14th. They set an “overweight” rating and a $60.00 target price on the stock. Wall Street Zen upgraded Amrize to a “hold” rating in a report on Saturday, October 25th. Citigroup increased their target price on Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Royal Bank Of Canada lifted their price target on Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a research report on Thursday. Finally, Oppenheimer reiterated an “outperform” rating and issued a $70.00 price objective (up previously from $64.00) on shares of Amrize in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $63.43.

Amrize Trading Up 1.4%

Amrize stock traded up $0.86 during trading hours on Friday, reaching $64.78. The stock had a trading volume of 306,792 shares, compared to its average volume of 3,467,883. The company has a fifty day simple moving average of $55.91 and a 200-day simple moving average of $52.38. Amrize has a 52 week low of $44.12 and a 52 week high of $64.83. The stock has a market cap of $35.83 billion and a PE ratio of 35.36. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 0.97.

Amrize (NYSE:AMRZ) last posted its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion for the quarter, compared to analysts’ expectations of $2.95 billion. The company’s quarterly revenue was down .4% compared to the same quarter last year.

Hedge Funds Weigh In On Amrize

Several hedge funds and other institutional investors have recently bought and sold shares of AMRZ. Invesco Ltd. lifted its position in Amrize by 27.2% during the fourth quarter. Invesco Ltd. now owns 571,266 shares of the company’s stock valued at $30,894,000 after purchasing an additional 122,027 shares during the period. Alberta Investment Management Corp purchased a new stake in Amrize during the 4th quarter valued at $13,039,000. Mercer Global Advisors Inc. ADV lifted its holdings in shares of Amrize by 197.5% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,944 shares of the company’s stock valued at $862,000 after buying an additional 10,584 shares during the period. Beacon Pointe Advisors LLC purchased a new position in shares of Amrize in the 4th quarter worth $935,000. Finally, Mackenzie Financial Corp grew its holdings in shares of Amrize by 26.6% in the fourth quarter. Mackenzie Financial Corp now owns 57,743 shares of the company’s stock worth $3,169,000 after acquiring an additional 12,146 shares during the period.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.